Search results
GSK Completes Demerger of Consumer Healthcare Business
Zacks via Yahoo Finance· 2 years agoPost demerger, GSK is set to focus on its Pharmaceuticals and Vaccines businesses. The consumer...
Is GSK Stock Worth Buying Right Now?
Motley Fool· 10 months agoGSK (NYSE: GSK), a global healthcare company, initiated the separation of its consumer healthcare business, Haleon, last year, as part of its ambitious...
GSK to sell 2.9% stake in former consumer healthcare business Haleon
Reuters via AOL· 8 months agoThe sale will bring down GSK's current 10.3% holding in the Sensodyne maker, which was spun out and...
GSK Trims Stake On Consumer Business Spin Off, Raises £804M
Benzinga via Yahoo Finance· 1 year agoGSK Plc (NYSE: GSK) sold 240 million shares of its spun-out consumer healthcare group Haleon Plc...
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
Pharma Stock Roundup: JNJ, NVS Q2 Earnings, GSK Consumer Unit Spin-Off
Zacks via Yahoo Finance· 2 years agoThis week, J&J JNJ set in motion the second-quarter earnings season for the drug and biotech sector...
This Analyst Says GSK Spin-Off Haleon Offers "Best Of Both Consumer Worlds"
Benzinga via Yahoo Finance· 2 years agoCiti group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc...
GSK's Q3 Earnings Beat, Ups 2022 Sales Outlook, Stock Up
Zacks via Yahoo Finance· 2 years agoGSK plc GSK reported third-quarter 2022 adjusted earnings of $1.09 per American depositary share...
FTSE 100: GSK lifts profit and sales guidance amid strong demand for vaccines
Yahoo Finance UK· 2 years agoGSK beat third-quarter earnings forecasts. Photo: Peter Nicholls/Reuters Peter Nicholls / reuters...
GSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
Zacks via Yahoo Finance· 6 months agoStrong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and...
